Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study.
| Title: | Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study. |
|---|---|
| Authors: | Declercq PL; Service de Médecine Intensive Réanimation, CH de Dieppe, Dieppe, France.; Fournel I; Centre d'Investigation Clinique, CHU Dijon, Dijon, France.; INSERM, CIC 1432, Module Epidémiologie Clinique, Dijon, France.; Demeyere M; Service de Radiologie, CHU Rouen, 76000, Rouen, France.; Berraies A; Service de Pneumologie, CH Chartres, Chartres, France.; Ksiazek E; Centre d'Investigation Clinique, CHU Dijon, Dijon, France.; INSERM, CIC 1432, Module Epidémiologie Clinique, Dijon, France.; Nyunga M; Service de Médecine Intensive Réanimation, CH de Roubaix, Roubaix, France.; Daubin C; Department of Medical Intensive Care, CHU de Caen Normandie, Caen, France.; Ampere A; Service de Pneumologie, CH de Béthune, Béthune, France.; Sauneuf B; Service de Médecine Intensive Réanimation, CH Public du Cotentin, Cherbourg-en-Cotentin, France.; Badie J; Service de Médecine Intensive Réanimation, Hopital Nord Franche-Comte, Trevenans, France.; Delbove A; Service de Réanimation Polyvalente, CHBA Vannes, Vannes, France.; Nseir S; Service de Médecine Intensive Réanimation, CHRU Roger Salengro, Lille, France.; Inserm U1285, Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France.; Artaud-Macari E; University of Normandie, UNIROUEN, EA3830, CHU Rouen, Department of Pneumology, Thoracic Oncology and Respiratory Intensive Care Unit, Rouen, France.; Bironneau V; Service de Pneumologie, CHU Poitiers, Poitiers, France.; INSERM CIC 1402, ALIVES Research Group, Université de Poitiers, Poitiers, France.; Ramakers M; Service de Médecine Intensive Réanimation, Centre Hospitalier Mémorial de Saint-Lô, Saint-Lô, France.; Maizel J; Service de Médecine Intensive Réanimation, CHU d'Amiens, Amiens, France.; Miailhe AF; Service de Médecine Intensive Réanimation, CHU Nantes, Nantes, France.; Lacombe B; Service de Réanimation Polyvalente, Groupe Hospitalier Bretagne Sud, Lorient, France.; Delberghe N; Service de Pneumologie, CHES Evreux, Évreux, France.; Oulehri W; Service de Réanimation Chirurgicale, CHRU Strasbourg, Strasbourg, France.; Georges H; Service de Médecine Intensive Réanimation, CH de Tourcoing, Tourcoing, France.; Tchenio X; Service de Réanimation Polyvalente, Centre Hospitalier Fleyriat, Bourg en Bresse, France.; Clarot C; Service de Pneumologie, CH d'Abbeville, Abbeville, France.; Redureau E; Service de Pneumologie, CHD Vendée, La Roche-sur-Yon, France.; Bourdin G; Service de Réanimation Polyvalente, CH Saint Joseph Saint Luc, Lyon, France.; Federici L; Service de Médecine Intensive Réanimation, AP-HP, Hôpital Louis Mourier, Colombes, France.; Adda M; Service de Médecine Intensive Réanimation, Hôpitaux de Marseille, Hôpital Nord, Marseille, France.; Schnell D; Service de Réanimation Polyvalente et USC, CH d'Angoulême, Angoulême, France.; Bousta M; Service de Réanimation Médico-Chirugicale, Groupe Hospitalier du Havre, Le Havre, France.; Salmon-Gandonnière C; Service de Médecine Intensive Réanimation, CHRU de Tours, Tours, France.; Vanderlinden T; Intensive Care Unit, St Philibert hospital, ETHICS EA 7446, Lille Catholic University, Lille, France.; Plantefeve G; Service de Médecine Intensive Réanimation, CH d'Argenteuil, Argenteuil, France.; Delacour D; Service de radiologie, Clinique du Cèdre, Bois-Guillaume, France.; Delpierre C; CERPOP, Université de Toulouse, Inserm, Toulouse, France.; Le Bouar G; Service de Médecine Intensive Réanimation, CHES Evreux, Evreux, France.; Sedillot N; Service de Réanimation Polyvalente, Centre Hospitalier Fleyriat, Bourg en Bresse, France.; Beduneau G; Normandie Univ, UNIROUEN, UR3830, CHU Rouen, Department of Medical Intensive Care, 76000, Rouen, France.; Rivière A; Service de Réanimation Polyvalente, CH d'Abbeville, Abbeville, France.; Meunier-Beillard N; Centre d'Investigation Clinique, CHU Dijon, Dijon, France.; INSERM, CIC 1432, Module Epidémiologie Clinique, Dijon, France.; Gélinotte S; Service de Médecine Intensive Réanimation, CH de Dieppe, Dieppe, France.; Rigaud JP; Service de Médecine Intensive Réanimation, CH de Dieppe, Dieppe, France.; Espace de Réflexion Ethique de Normandie, CHU Caen, Caen, France.; Labruyère M; Department of Intensive Care, Burgundy University Hospital, 14 rue Paul Gaffarel, B.P 77908, 21079, Dijon Cedex, France.; Lipness Team, INSERM Research Center LNC-UMR1231 and LabEx LipSTIC, University of Burgundy, Dijon, France.; INSERM CIC 1432, Clinical Epidemiology, University of Burgundy, Dijon, France.; Georges M; Department of Pulmonary Medicine and Intensive Care Unit, University Hospital, Dijon, France.; Binquet C; Centre d'Investigation Clinique, CHU Dijon, Dijon, France.; INSERM, CIC 1432, Module Epidémiologie Clinique, Dijon, France.; Quenot JP; Department of Intensive Care, Burgundy University Hospital, 14 rue Paul Gaffarel, B.P 77908, 21079, Dijon Cedex, France. jean-pierre.quenot@chu-dijon.fr.; Lipness Team, INSERM Research Center LNC-UMR1231 and LabEx LipSTIC, University of Burgundy, Dijon, France. jean-pierre.quenot@chu-dijon.fr.; INSERM CIC 1432, Clinical Epidemiology, University of Burgundy, Dijon, France. jean-pierre.quenot@chu-dijon.fr. |
| Corporate Authors: | RECOVIDS trial investigators, the CRICS-TRIGGERSEP, BOREAL research networks |
| Source: | Intensive care medicine [Intensive Care Med] 2023 Oct; Vol. 49 (10), pp. 1168-1180. Date of Electronic Publication: 2023 Aug 24. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Springer Verlag Country of Publication: United States NLM ID: 7704851 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1238 (Electronic) Linking ISSN: 03424642 NLM ISO Abbreviation: Intensive Care Med Subsets: MEDLINE |
| Imprint Name(s): | Publication: New York : Springer Verlag; Original Publication: Berlin ; New York, Springer International. |
| MeSH Terms: | COVID-19*/complications ; Respiratory Distress Syndrome*/etiology ; Respiratory Distress Syndrome*/therapy; Humans ; SARS-CoV-2 ; Prospective Studies ; Economic Status ; Oxygen |
| Abstract: | Purpose: Survivors after acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19) are at high risk of developing respiratory sequelae and functional impairment. The healthcare crisis caused by the pandemic hit socially disadvantaged populations. We aimed to evaluate the influence of socio-economic status on respiratory sequelae after COVID-19 ARDS.; Methods: We carried out a prospective multicenter study in 30 French intensive care units (ICUs), where ARDS survivors were pre-enrolled if they fulfilled the Berlin ARDS criteria. For patients receiving high flow oxygen therapy, a flow ≥ 50 l/min and an FiO2 ≥ 50% were required for enrollment. Socio-economic deprivation was defined by an EPICES (Evaluation de la Précarité et des Inégalités de santé dans les Centres d'Examens de Santé - Evaluation of Deprivation and Inequalities in Health Examination Centres) score ≥ 30.17 and patients were included if they performed the 6-month evaluation. The primary outcome was respiratory sequelae 6 months after ICU discharge, defined by at least one of the following criteria: forced vital capacity |
| Comments: | Erratum in: Intensive Care Med. 2023 Nov;49(11):1438-1439. doi: 10.1007/s00134-023-07217-2.. (PMID: 37755457) |
| References: | Intensive Care Med. 2018 Dec;44(12):2025-2037. (PMID: 30353380); Eur J Public Health. 2015 Aug;25(4):604-9. (PMID: 25624273); Lancet Reg Health Eur. 2021 Feb;1:100005. (PMID: 34173618); J Epidemiol Community Health. 2020 Mar;74(3):290-297. (PMID: 31822567); N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013); Int J Chron Obstruct Pulmon Dis. 2009;4:9-18. (PMID: 19436682); Gerontologist. 1970 Spring;10(1):20-30. (PMID: 5420677); JAMA. 2020 Jun 2;323(21):2192-2195. (PMID: 32347898); J Health Soc Behav. 1995;Spec No:80-94. (PMID: 7560851); JAMA. 2020 Jun 2;323(21):2191-2192. (PMID: 32338732); Eur Respir J. 2012 Dec;40(6):1324-43. (PMID: 22743675); Chest. 2016 Jan;149(1):238-51. (PMID: 26356330); Eur Respir J. 2014 Dec;44(6):1428-46. (PMID: 25359355); JAMA. 2020 Apr 7;323(13):1239-1242. (PMID: 32091533); Respir Care. 2016 May;61(5):689-99. (PMID: 27121623); Intensive Care Med. 2022 Dec;48(12):1803-1806. (PMID: 36074167); Int J Environ Res Public Health. 2019 Jan 20;16(2):. (PMID: 30669511); Sci Rep. 2022 Jul 15;12(1):12133. (PMID: 35840691); Lancet. 2021 Jan 16;397(10270):220-232. (PMID: 33428867); Ann Intensive Care. 2020 Feb 11;10(1):20. (PMID: 32048075); JAMA. 2021 Apr 20;325(15):1525-1534. (PMID: 33729425); Complement Ther Clin Pract. 2020 May;39:101166. (PMID: 32379637); Eur J Emerg Med. 2020 Aug;27(4):274-278. (PMID: 32516161); Lancet Public Health. 2021 Sep;6(9):e683-e691. (PMID: 34252364); J Health Econ. 2004 Sep;23(5):965-95. (PMID: 15353189); JAMA. 2016 Jun 28;315(24):2694-702. (PMID: 27367766); Clinics (Sao Paulo). 2021 Jun 14;76:e2804. (PMID: 34133481); ERJ Open Res. 2021 Feb 08;7(1):. (PMID: 33585658); Occup Med (Lond). 2017 Aug 1;67(6):496-497. (PMID: 28898975); J Epidemiol Community Health. 2012 Nov;66(11):982-9. (PMID: 22544918); Intensive Care Med. 2021 Jan;47(1):60-73. (PMID: 33211135); J Hand Surg Am. 2022 Jul;47(7):655-661. (PMID: 35623922); BMJ Open. 2018 May 5;8(5):e019998. (PMID: 29730622); Eur Respir J. 2017 Jan 3;49(1):. (PMID: 28049168); Lancet Infect Dis. 2020 Aug;20(8):e192-e197. (PMID: 32539990); Crit Care Med. 2023 Mar 01;51(3):347-356. (PMID: 36728845); Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):180-182. (PMID: 32164083); Am J Public Health. 1992 Jun;82(6):816-20. (PMID: 1585961); JAMA. 2012 Jun 20;307(23):2526-33. (PMID: 22797452); Int J Environ Res Public Health. 2022 Jul 25;19(15):. (PMID: 35897400); Radiology. 2008 Mar;246(3):697-722. (PMID: 18195376); Health Aff (Millwood). 2002 Mar-Apr;21(2):60-76. (PMID: 11900187); Eur Respir J. 2021 Apr 29;57(4):. (PMID: 33419891); J Community Health. 2021 Aug;46(4):794-802. (PMID: 33387149); J Appl Physiol (1985). 2010 Jan;108(1):206-11. (PMID: 19875713); BMJ Open. 2022 Apr 22;12(4):e057368. (PMID: 35459672); Diabetes Metab. 2012 Feb;38(1):82-5. (PMID: 22172401); N Engl J Med. 2003 Feb 20;348(8):683-93. (PMID: 12594312); Chest. 2021 Jul;160(1):187-198. (PMID: 33676998); Lancet. 2022 Jun 25;399(10344):2381-2397. (PMID: 35247311); Health Sci Rep. 2022 May 05;5(3):e628. (PMID: 35539445); Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. (PMID: 31613151); Lancet Respir Med. 2021 Nov;9(11):1275-1287. (PMID: 34627560); J Korean Med Sci. 2022 Aug 29;37(34):e262. (PMID: 36038958); Eur J Phys Rehabil Med. 2021 Apr;57(2):189-198. (PMID: 33448756) |
| Contributed Indexing: | Investigator: M De Jesus; S Normant; JN Dacher; T Stoup; C Vinsonneau; A Dewatine; P Cuchet; D Rots; J Calus; G Le Moel; P Kalfon; G Badre; JF Roy; D Roux; JD Ricard; M Marcq; T Georges; C Pouplet; L Lagache; N Masson; M Devos; R Favory; S Preau; A Gaudet; P Bouju; L Nichita; P Maignan; L Labourot; F Molinari; L Thirard; C Larrat; F Berdaguer; MK Akgun; Y Fedun; T Guy; M Gousseff; D Boyer; T Bonnevie; E Demarest; S Hraiech; A Sylvestre; C Sanz; A Veinstein; Keywords: ARDS; COVID-19; Deprivation; Respiratory sequelae; Socio-economic |
| Substance Nomenclature: | S88TT14065 (Oxygen) |
| Entry Date(s): | Date Created: 20230824 Date Completed: 20231103 Latest Revision: 20251121 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC10556111 |
| DOI: | 10.1007/s00134-023-07180-y |
| PMID: | 37620561 |
| Database: | MEDLINE |
Journal Article